Monday, July 18, 2011

Hemophilia is most costly illness in Taiwan

Treatment for each hemophilia patient costs the government NT$2.56 million (S$109,312) annually on average, an official with the Bureau of National Health Insurance (BNHI) under the Department of Health (DOH) said yesterday.

Treatment for such patients is most expensive because long-term use of coagulation factors is called for, Lin Are-ming, BNHI commissioner, said. The NT$2.56 million spent on each one of them is 120 times the medical expense of average patients.

BNHI statistics shows, 27 percent of the monthly health insurance premiums paid by the insured goes to medical treatment for victims of serious diseases or injuries. Treatment for hemophilia patients is most expensive, follow by treatment for patients kept alive by respirators and renal dialyses.

In 2010, the number of people suffering from serious diseases or injuries cam to more than 820,000, and of 40,000 people issued new medical insurance cards, more than half were cancer patients, according to Lin.

If the average medical insurance premium payable each year is NT$4,988, a single hemophilia patient would need the support of 182 premium-paying fellow citizens. Medical treatment for a patient on respirator costs about NT$670,000 a year, and that for each patient that needs renal dialysis, more than NT$560,000 a year.

According to Lin, per capita medical care expense in Taiwan is about NT$21,000 a year.

Hemophilia is most costly illness (in Taiwan)

1 comment:

joshed said...

That's expensive.

Related Posts Plugin for WordPress, Blogger...